Takara Bio Market Cap

Takara Bio has a market cap or net worth of 96.45 billion as of July 3, 2025. Its market cap has decreased by -20.54% in one year.

Market Cap

96.45B

Enterprise Value

68.35B

Revenue

45.04B

Ranking

n/a

PE Ratio

92.65

Stock Price

801.00

Market Cap Chart

Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 96.45B, an increase of 76.99%. That is a compound annual growth rate of 2.81%.

Market Cap History

Date	Market Cap	% Change
Jul 4, 2025	96.45B	-23.71%
Dec 30, 2024	126.44B	-16.13%
Dec 29, 2023	150.76B	-27.34%
Dec 30, 2022	207.48B	-34.83%
Dec 30, 2021	318.38B	-4.48%
Dec 30, 2020	333.31B	34.56%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	11.91T
Takeda Pharmaceutical Company	6,862.72B
Daiichi Sankyo Company	6,195.42B
HOYA Corporation	5,706.93B
Terumo	3,837.82B
Otsuka Holdings	3,606.59B
Astellas Pharma	2,490.04B
Shionogi &	2,167.97B

Market Cap Rankings